Results vary by individual based on age, genetics, baseline health, and treatment adherence
Read article Regulatory context 7 min read FDA Announces July 2026 Review of BPC-157, TB-500, Semax, Epitalon and Other Peptides Neutral research catalog context for the FDA's July 23-24, 2026 advisory committee agenda covering several peptide-related bulk drug substances
(PubMed) The same review warns that systemic administration (IV) may shift melanin production, altering skins natural photoprotection and potentially increasing the risk of UV-induced skin damage or cancer a risk especially relevant in sunny climates
Request an Appointment Internal Medicine Medical Weight Loss Weight Loss Medications Semaglutide/Tirzepatide Injections Lipotropic Injections Meal Replacement Diet and Nutrition BMI Calculator Cool Body Sculpting Alternative Medicine IV Therapy NAD+ IV Infusion Allergy Treatments Diet Supplements Platelet Rich Plasma Therapy Clinical Studies Beautification Aquafacials Botox and Dermal Fillers Cool Body Sculpting Platelet Rich Plasma Therapy Radiofrequency (RF) Microneedling Thread Lift UltraMD Laser Our Providers Dr
Immunosuppressive therapy may alter the downstream effects of HGF/c-Met activation by dihexa
These studies confirm its safety for topical applications